Literature DB >> 24983214

Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet?

Marcos I Restrepo1, Antonio Anzueto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24983214      PMCID： PMC4226034          DOI： 10.1164/rccm.201406-1014ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  17 in total

1.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Azithromycin for prevention of exacerbations of COPD.

Authors:  Richard K Albert; John Connett; William C Bailey; Richard Casaburi; J Allen D Cooper; Gerard J Criner; Jeffrey L Curtis; Mark T Dransfield; Meilan K Han; Stephen C Lazarus; Barry Make; Nathaniel Marchetti; Fernando J Martinez; Nancy E Madinger; Charlene McEvoy; Dennis E Niewoehner; Janos Porsasz; Connie S Price; John Reilly; Paul D Scanlon; Frank C Sciurba; Steven M Scharf; George R Washko; Prescott G Woodruff; Nicholas R Anthonisen
Journal:  N Engl J Med       Date:  2011-08-25       Impact factor: 91.245

3.  Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease.

Authors:  Zhi-Yi He; Li-Mei Ou; Jian-Quan Zhang; Jing Bai; Guang-Nan Liu; Mei-Hua Li; Jing-Min Deng; William MacNee; Xiao-Ning Zhong
Journal:  Respiration       Date:  2010-09-28       Impact factor: 3.580

4.  Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.

Authors:  MeiLan K Han; Nabihah Tayob; Susan Murray; Mark T Dransfield; George Washko; Paul D Scanlon; Gerard J Criner; Richard Casaburi; John Connett; Stephen C Lazarus; Richard Albert; Prescott Woodruff; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

5.  Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease.

Authors:  Sandra Hodge; Greg Hodge; Hubertus Jersmann; Geoffrey Matthews; Jessica Ahern; Mark Holmes; Paul N Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

6.  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Authors:  Jadwiga A Wedzicha; Peter M A Calverley; Terence A Seemungal; Gerry Hagan; Zainab Ansari; Robert A Stockley
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

7.  Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.

Authors:  Terence A R Seemungal; Tom M A Wilkinson; John R Hurst; Wayomi R Perera; Ray J Sapsford; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2008-08-21       Impact factor: 21.405

8.  Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.

Authors:  Xavier Pomares; Concepción Montón; Mateu Espasa; Jordi Casabon; Eduard Monsó; Miguel Gallego
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-09-06

9.  Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Sanjay Sethi; Paul W Jones; Marlize Schmitt Theron; Marc Miravitlles; Ethan Rubinstein; Jadwiga A Wedzicha; Robert Wilson
Journal:  Respir Res       Date:  2010-01-28

Review 10.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321
View more
  4 in total

1.  Assessing potential risks of treatment with long-term azithromycin in COPD patients: long-term oxygen users beware?

Authors:  T T Nicholson; A Franciosi; S Landers; M W Butler
Journal:  Ir J Med Sci       Date:  2015-10-26       Impact factor: 1.568

2.  Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation.

Authors:  Guido A Gualdoni; Tilman Lingscheid; Klaus G Schmetterer; Annika Hennig; Peter Steinberger; Gerhard J Zlabinger
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

3.  Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations.

Authors:  Marjolein Brusse-Keizer; Paul VanderValk; Ron Hendrix; Huib Kerstjens; Job van der Palen
Journal:  BMJ Open Respir Res       Date:  2014-12-30

4.  Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model.

Authors:  Xiaoyu Liu; Cuiqing Ma; Xiaoyu Wang; Wenjing Wang; Zhu Li; Xiansheng Wang; Pengyu Wang; Wuzhuang Sun; Baojian Xue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.